|
|
(Transportation-News.com, August 24, 2018 ) Publisher's new report, United States In Vitro Diagnostics (IVD) Market Outlook to 2024, provides key market data on the United States In Vitro Diagnostics (IVD) market. The report provides value, in millions of US dollars and volume (in units) within market categories-Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics, Microbiology Culture.
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Request a Sample Report@ http://www.reportsweb.com/inquiry&RW00011298510/sample
Report Scope:
-Market size and company share data for In Vitro Diagnostics (IVD) market categories-Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics, Microbiology Culture.
-Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2010 to 2017 and forecast to 2024.
-2017 company shares and distribution shares data for each of the market categories.
-Global corporate-level profiles of key companies operating within the United States In Vitro Diagnostics (IVD) market.
-Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Sysmex Corp, Siemens Healthcare GmbH, Beckman Coulter Inc, Thermo Fisher Scientific Inc and Others
Reasons to buy:
-Develop business strategies by identifying the key market segments poised for strong growth in the future.
-Develop market-entry and market expansion strategies.
-Design competition strategies by identifying who-stands-where in the market.
-Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
-What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.
Inquire before Buying@ http://www.reportsweb.com/inquiry&RW00011298510/buying
Companies Mentioned:
F. Hoffmann-La Roche Ltd
Beckman Coulter Inc
Abbott Laboratories
Becton Dickinson and Co
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc
Hologic Inc
Sysmex Corp
bioMerieux SA
Ortho-Clinical Diagnostics Inc
Bio-Rad Laboratories Inc
Qiagen NV
Alere Inc
DiaSorin S.p.A
Table of Contents:
1 Table of Contents 2
2 Introduction 24
3 In Vitro Diagnostics Market, United States 51
4 Clinical Chemistry Market, United States 70
5 Genetic Testing Market, United States 140
6 Hematology Market, United States 149
7 Histology And Cytology Market, United States 203
8 Immuno Chemistry Market, United States 213
9 Infectious Diagnostics Market, United States 291
10 Microbiology Culture Market, United States 399
11 Overview of Key Companies in United States, In Vitro Diagnostics Market 417
12 In Vitro Diagnostics Market Pipeline Products 421
13 Financial Deals Landscape 425
14 Recent Developments 1084
15 Appendix 2656
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
